ÇѸ²´ëÇб³¼º½Éº´¿ø ºñ´¢±âÁúȯÀÇ ÃÖ½ÅÁö°ß ¹× °³¿ø°¡¿¡¼ ÈçÈ÷ Á¢ÇÏ´Â Áúȯ : 2019-10-13±³À°ÀÏÀÚ : 2019-10-13
±³À°Àå¼Ò : ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ
±³À°ÁÖÁ¦ :
ºñ´¢±âÁúȯÀÇ ÃÖ½ÅÁö°ß ¹× °³¿ø°¡¿¡¼ ÈçÈ÷ Á¢ÇÏ´Â ÁúȯÁÖÃÖ±â°ü : ÇѸ²´ëÇб³¼º½Éº´¿ø
½ÃÇà±â°ü(ÁöºÎ/°ú) : ºñ´¢±â°ú
´ã´çÀÚ : ¹æ¿ìÁø
¿¬¶ôó : 031-380-3850
À̸ÞÀÏ :
yybbang@gmail.com Âü¼®¿¹»óÀοø : 40¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 14:00~14:30 Principles of clinical use of botulinum toxin ¼Ã¢´ö(Âü¸¼ÀºÀÇ¿ø)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 14:30~15:00 ·¹ÀÌÀúÀÇ ¿ø¸®¿Í »ç¿ë À嵿±Ô(¾ÆºñÁêÀÇ¿ø)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 15:00~15:30 °íÁöÇ÷ÁõÀÇ Ä¡·á ±èö½Ä(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 15:30~16:00 °ñ´Ù°øÁõÀÇ Ä¡·á ÃÖÀÏ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 16:00~16:30 AUS for the management of PPI °í±¤Áø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 16:30~17:00 ¼Ò¾Æ ¹è´¢Àå¾Ö ȯÀÚÀÇ ÃÖ½ÅÁö°ß ÀÌÁ¤ÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 17:00~17:30 Role of MRI before prostate biopsy ½É¸í¼±(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 10-13 ÇѸ²´ëÇб³¼º½Éº´¿ø Á¦2º°°ü 5Ãþ Àϼ۹®ÈȦ 17:30~18:00 Nonantibiotic option of recurrent urinary tract infection ÃÖâÀÏ(ÇѸ²ÀÇ´ë)